Laboratory Corporation of America Holdings

NYSE:LH

227.22 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994199319921991199019891988
Revenue 12,161.614,876.816,120.913,978.511,554.811,333.410,441.49,641.88,680.16,011.65,808.35,671.45,542.35,003.94,694.74,505.24,068.23,590.83,327.63,084.82,939.42,507.72,199.81,919.31,698.71,612.61,5191,607.71,432872.5760.5721.4603.9501.9402.4313.9
Cost of Revenue 9,016.510,491.710,496.69,025.78,302.38,1576,977.46,461.35,776.83,808.53,585.13,421.73,267.62,906.12,723.82,631.42,3772,061.41,937.31,795.51,714.81,445.91,274.21,096.61,016.3995.81,024.31,129978.9568.9421.4376.5310.5260.9211.30
Gross Profit 3,145.14,385.15,624.34,952.83,252.53,176.43,4643,180.52,903.32,203.12,223.22,249.72,274.72,097.81,970.91,873.81,691.21,529.41,390.31,289.31,224.61,061.8925.6822.7682.4616.8494.7478.7453.1303.6339.1344.9293.4241191.1313.9
Gross Profit Ratio 0.2590.2950.3490.3540.2810.280.3320.330.3340.3660.3830.3970.410.4190.420.4160.4160.4260.4180.4180.4170.4230.4210.4290.4020.3820.3260.2980.3160.3480.4460.4780.4860.480.4751
Reseach & Development Expenses 200000000000000000000000000000000000
General & Administrative Expenses 0000000000000000000000516.5483448.2405499.9490313.5149.3000000
Selling & Marketing Expenses 000000000000000000000000000000000000
SG&A 2,021.41,996.61,952.11,729.31,624.51,570.91,812.41,630.21,6221,198.21,128.81,114.61,159.61,034.3958.9935.1808.7779.1703.9649.1651.8585.5516.5483448.2405499.9490313.5149.3121.4117.997.982.2650
Other Expenses 15.5259.3369.6275.4243.2167.7-7.62.6-7.810.42.1-7.285.872.762.657.954.952.251.442.737.623.841.589.684.584.286.884.572.444.432.226.92218.413.30
Operating Expenses 2,021.42,255.92,321.72,004.71,867.71,802.62,028.91,809.71,786.51,274.91,210.51,200.91,245.41,1071,021.51,030.9863.6831.3755.3691.8689.4609.3558572.6532.7489.2586.7574.5385.9193.7153.6144.8119.9100.678.30
Operating Income 1,123.71,773.93,259.52,445.41,330.21,325.71,364.21,312.41,002.9910.4990.91,023.5948.4978.8935.9842.9777697.1618.1598.4533.7435367.6250.1149.7127.6-92-95.867.2109.9185.5200.1173.5140.4112.8313.9
Operating Income Ratio 0.0920.1190.2020.1750.1150.1170.1310.1360.1160.1510.1710.180.1710.1960.1990.1870.1910.1940.1860.1940.1820.1730.1670.130.0880.079-0.061-0.060.0470.1260.2440.2770.2870.280.281
Total Other Income Expenses Net -554.8-191.3-132.9-226.3-225.3138.7-65.1-46.2-109.886.6-10.1-77-16.9-17.3-2.131.370.640.153.946.1-4.7-8.3-4-2.62.62.4-20.81.4-2016.5-133.8-4.2-3.3-50
Income Before Tax 568.91,582.63,126.62,219.11,104.91,268.31,134.91,105.5732.1826.7915.6944.2866.1915.6884.6772.4802.3720.9640.7615.3540.4432.3332.3207.6105.581.5-161.3-188.33.155.4191.162.1169.3137.1107.80
Income Before Tax Ratio 0.0470.1060.1940.1590.0960.1120.1090.1150.0840.1380.1580.1660.1560.1830.1880.1710.1970.2010.1930.1990.1840.1720.1510.1080.0620.051-0.106-0.1170.0020.0630.2510.0860.280.2730.2680
Income Tax Expense 188.5302747.1662.1280384.4-139.1372.3294.1314.1340.2359.4333344329307.9325.5289.3254.5252.3219.4177.7149.695.540.112.7-54.4-34.87.125.378.421.565.454.543.10
Net Income 4181,279.12,377.31,556.1823.8883.71,268.2732.1436.9511.2573.8583.1519.7558.2543.3464.5476.8431.6386.2363321254.6179.5112.165.468.8-106.9-153.5-12.330.1112.740.6103.982.664.70
Net Income Ratio 0.0340.0860.1470.1110.0710.0780.1210.0760.050.0850.0990.1030.0940.1120.1160.1030.1170.120.1160.1180.1090.1020.0820.0580.0390.043-0.07-0.095-0.0090.0340.1480.0560.1720.1650.1610
EPS 4.814.0424.5815.998.418.7112.397.144.426.036.76.245.315.454.984.64.083.482.892.62.231.781.290.830.30.5-2.17-3.12-0.270.93.151.082.632.081.631.25
EPS Diluted 4.7713.9624.3815.888.368.6112.217.024.345.916.255.995.115.294.984.63.933.242.712.452.111.771.270.810.290.5-2.17-3.12-0.270.93.151.082.632.081.631.25
EBITDA 1,704.62,743.24,116.73,543.61,968.62,105.21,9721,880.51,576.81,198.41,113.41,149.31,125.91,075.21,027.4904.41,037849.2803733.7668.4572.4479.9343.7236.8209.2-7.69.5138.2174.3201.2360.8199.7162.1131.1313.9
EBITDA Ratio 0.140.1840.2550.2540.170.1860.1890.1950.1820.1990.1920.2030.2030.2150.2190.2010.2550.2360.2410.2380.2270.2280.2180.1790.1390.13-0.0050.0060.0970.20.2650.50.3310.3230.3261